Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cecolin 9 in Healthy Women Aged 18-45 Years
NCT04537156Phase 3Active, not recruiting
- Sponsor
- Xiamen University
- Start
- Sep 2020
- Primary completion
- Dec 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Cecolin 9 in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), Cervical Cancer (CC), condylomata acuminata, sponsored by Xiamen University. Started Sep 2020; status: active, not recruiting.
02
Drugs
Cecolin 9
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)Cervical Cancer (CC)condylomata acuminata
Beyond the preview
Go deeper on NCT04537156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04537156.